trending Market Intelligence /marketintelligence/en/news-insights/trending/93926JGdhpuQeXDqDDAIVQ2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

Endo to refinance $1B of existing senior notes, raise additional debt

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

Endo to refinance $1B of existing senior notes, raise additional debt

Endo International PLC said it will refinance debt in a series of transactions that would include buying nearly $1 billion worth of its outstanding senior notes.

The Dublin-based drugmaker's wholly owned unit Endo Finance LLC will launch the cash tender offers subject to the condition that the total consideration paid does not exceed $1 billion.

The notes to be bought back include 7.25% senior notes due 2022, 5.75% senior notes due 2022, 5.375% senior notes due 2023 and 6.000% senior notes due 2023.

The company is also seeking to extend the maturity of its revolving credit facility from April 2022 to March 2024 along with modifications to certain conditions.

The tender offers are subject to Endo raising financing in gross proceeds of an aggregate principal amount of at least $1 billion. The funds can be raised either by issuing additional secured debt or by borrowing from the company's existing credit facilities.